BL
BRKR icon

Balentine LLC’s Bruker BRKR Stock Holding History

Balentine LLC’s Portfolio BRKR Stock Details BRKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,402
Closed -$320K – 233
2024
Q1 		$320K Sell
3,402
-17
-0.5% -$1.37K 0.01% 386
2023
Q4 		$251K Buy
+3,419
New +$219K 0.01% 437

Other funds holding BRKR

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCA
Pallas Capital Advisors Braintree, Massachusetts $2.66B AUM 22.31% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LCOV
London Company of Virginia Richmond, Virginia $16.2B AUM 17.5% 1-Year Est. Return

Balentine LLC's BRKR Position: Q2 2024 in Review

Balentine LLC sold out of Bruker (BRKR) in Q2 2024, closing a stake of 3,402 shares — an estimated $320K sold.

Balentine LLC first reported a position in BRKR in Q4 2023 and held it in 2 quarters. The position peaked at $320K in Q1 2024. 365 funds tracked by Wall St. Rank hold BRKR as of Q2 2024.

  • Balentine LLC reported no remaining Bruker position as of Q2 2024 after selling out during the quarter.
  • Balentine LLC sold 3,402 Bruker shares in Q2 2024, an estimated $320K.
  • Balentine LLC first reported a position in Bruker in Q4 2023 and held it in 2 quarters.
  • Balentine LLC's Bruker position peaked at $320K in Q1 2024.
  • 365 funds tracked by Wall St. Rank held Bruker as of Q2 2024.

Based on Balentine LLC's 13F filing for Q2 2024, filed 7 Aug 2024.